The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $25.30

Today's change-1.45 -5.42%
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $25.30

Today's change-1.45 -5.42%
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.

PharMerica Corp crosses below 200-day moving average

PharMerica Corp closed sharply lower Friday, dropping (U.S.)$1.45 or 5.42% to (U.S.)$25.30 and crossing below its 200-day moving average. Shares have lost 3.80% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 39.59% during the last year.

Key company metrics

  • Open(U.S.) $26.50
  • Previous close(U.S.) $26.75
  • High(U.S.) $26.50
  • Low(U.S.) $23.53
  • Bid / Ask-- / --
  • YTD % change+0.60%
  • Volume625,816
  • Average volume (10-day)185,938
  • Average volume (1-month)168,799
  • Average volume (3-month)243,241
  • 52-week range(U.S.) $19.20 to (U.S.) $31.02
  • Beta1.16
  • Trailing P/E22.84×
  • P/E 1 year forward12.41×
  • Forward PEG2.82×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.11
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue534513520525
Total other revenue--------
Total revenue534513520525
Gross profit84798282
Total cost of revenue451434438443
Total operating expense523501512517
Selling / general / administrative55535657
Research & development--------
Depreciation / amortization9888
Interest expense (income), net operating--------
Unusual expense (income)95109
Other operating expenses, total--------
Operating income111288
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax11945
Income after tax8734
Income tax, total3221
Net income8734
Total adjustments to net income--------
Net income before extra. items8734
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8734
Inc. avail. to common incl. extra. items8734
Diluted net income8734
Dilution adjustment--------
Diluted weighted average shares32313131
Diluted EPS excluding extraordinary itemsvalue per share0.240.230.080.13
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.450.370.280.38